Lineage Cell (Israel) Buy Hold or Sell Recommendation
BTX Stock | ILS 447.30 14.00 3.23% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Lineage Cell Therapeutics is 'Strong Sell'. Macroaxis provides Lineage Cell buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BTX positions. The advice algorithm takes into account all of Lineage Cell's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Lineage Cell's buy or sell advice are summarized below:
Real Value 383.06 | Hype Value 447.3 | Market Value 447.3 | Naive Value 385.22 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Lineage Cell Therapeutics given historical horizon and risk tolerance towards Lineage Cell. When Macroaxis issues a 'buy' or 'sell' recommendation for Lineage Cell Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Lineage |
Execute Lineage Cell Buy or Sell Advice
The Lineage recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lineage Cell Therapeutics. Macroaxis does not own or have any residual interests in Lineage Cell Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lineage Cell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Lineage Cell Trading Alerts and Improvement Suggestions
Lineage Cell had very high historical volatility over the last 90 days | |
The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M. | |
Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. |
Lineage Cell Returns Distribution Density
The distribution of Lineage Cell's historical returns is an attempt to chart the uncertainty of Lineage Cell's future price movements. The chart of the probability distribution of Lineage Cell daily returns describes the distribution of returns around its average expected value. We use Lineage Cell Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lineage Cell returns is essential to provide solid investment advice for Lineage Cell.
Mean Return | 0.26 | Value At Risk | -6.05 | Potential Upside | 10.76 | Standard Deviation | 5.49 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lineage Cell historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lineage Cell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lineage Cell or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lineage Cell's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lineage stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.15 | |
β | Beta against NYSE Composite | 1.23 | |
σ | Overall volatility | 5.83 | |
Ir | Information ratio | 0.03 |
Lineage Cell Volatility Alert
Lineage Cell Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lineage Cell's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lineage Cell's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lineage Cell Fundamentals Vs Peers
Comparing Lineage Cell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lineage Cell's direct or indirect competition across all of the common fundamentals between Lineage Cell and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lineage Cell or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lineage Cell's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lineage Cell by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Lineage Cell to competition |
Fundamentals | Lineage Cell | Peer Average |
Price To Book | 1.14 X | 9.51 X |
Price To Sales | 39.20 X | 11.42 X |
Revenue | 4.99 M | 9.43 B |
Gross Profit | 4.69 M | 27.38 B |
EBITDA | (37.2 M) | 3.9 B |
Net Income | (45.99 M) | 570.98 M |
Cash And Equivalents | 27.1 M | 2.7 B |
Cash Per Share | 0.18 X | 5.01 X |
Total Debt | 5.09 M | 5.32 B |
Debt To Equity | 3.10 % | 48.70 % |
Current Ratio | 3.51 X | 2.16 X |
Book Value Per Share | 1.09 X | 1.93 K |
Cash Flow From Operations | (30.88 M) | 971.22 M |
Number Of Employees | 76 | 18.84 K |
Beta | 2.87 | -0.15 |
Market Capitalization | 512.15 M | 19.03 B |
Total Asset | 101.66 M | 29.47 B |
Z Score | 60.0 | 8.72 |
Net Asset | 101.66 M |
Lineage Cell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lineage . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lineage Cell Buy or Sell Advice
When is the right time to buy or sell Lineage Cell Therapeutics? Buying financial instruments such as Lineage Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lineage Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
View All Next | Launch |
Check out Lineage Cell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Lineage Stock analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
CEOs Directory Screen CEOs from public companies around the world | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |